Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 9, 2026

Oct. 9, 2026

Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease

Indeterminate GlobeNewswire

Oct. 9, 2026

CENTEL Announces Masternode Participation Model and Blockchain Development Roadmap

Indeterminate GlobeNewswire

Oct. 9, 2026

Stride to Appoint Steven Guttentag and Dylan Haggart to Board of Directors and Form Capital Allocation Committee

Indeterminate GlobeNewswire

Oct. 9, 2026

Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe

Indeterminate GlobeNewswire

Oct. 9, 2026

Chemtrade Logistics Income Fund Announces Plans for Conversion to A Simplified New Corporate Structure to Support Long Term Growth

Indeterminate GlobeNewswire

Oct. 9, 2026

Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference 

Indeterminate GlobeNewswire

Oct. 9, 2026

Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia

Indeterminate GlobeNewswire

Oct. 9, 2026

Balchem Corporation Announces Quarterly Conference Call for Third Quarter 2026 Financial Results on October 23, 2026

Indeterminate GlobeNewswire

Oct. 9, 2026

Barrick to Report Third Quarter 2026 Results on November 9

Indeterminate GlobeNewswire

Oct. 9, 2026

AI Crawlers Turned Away More Than Twice as Often, a Check to Run Before an AI Visibility Audit

Indeterminate GlobeNewswire

Oct. 9, 2026

Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Oct. 9, 2026

Sagimet To Present Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne and Mechanistic Data at the 2026 Fall Clinical Dermatology Conference

Indeterminate GlobeNewswire

Oct. 9, 2026

Wrap Appoints Veteran Law Enforcement Leader John “Chappy” Chapman as Vice President of Training and Missions

Indeterminate GlobeNewswire

Oct. 9, 2026

Aurora Mobile’s JPush Strengthens Shennong Group’s Messaging Infrastructure to Support Timely Delivery of Critical Business Information

Indeterminate GlobeNewswire

Oct. 9, 2026

PCI SSC veröffentlicht zusätzliche Leitlinien zur Absicherung von KI in Zahlungsumgebungen

Indeterminate GlobeNewswire

Oct. 9, 2026

Le PCI SSC publie de nouvelles recommandations pour sécuriser l’IA dans les environnements de paiement

Indeterminate GlobeNewswire

Oct. 9, 2026

Viomi Technology Co., Ltd Announces Board Changes

Indeterminate GlobeNewswire

Oct. 9, 2026

A promising new chapter for PI3Kδ inhibition: Nature Communications publications reveal novel mechanism behind iOnctura's roginolisib

Indeterminate GlobeNewswire

Oct. 9, 2026

Caregivers Need a Break: New No-Cost Day Program Opens in East St. Louis

Indeterminate GlobeNewswire

Oct. 9, 2026

EgyptAir Moves Passenger Experience into the AI Era with Sitecore

Indeterminate GlobeNewswire